NRG Oncology
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2014-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.nrgoncology.org
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Phase 3
Not yet recruiting
- Conditions
- Pancreas Cancer
- Interventions
- Radiation: Dose-escalated Radiation TherapyProcedure: Biopsy ProcedureProcedure: Computed TomographyProcedure: Magnetic Resonance ImagingOther: Questionnaire AdministrationRadiation: Radiation TherapyOther: Observation ActivityProcedure: Biospecimen Collection
- First Posted Date
- 2025-05-06
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 356
- Registration Number
- NCT06958328
E-Mindfulness Approaches for Living After Breast Cancer
Not Applicable
Not yet recruiting
- Conditions
- Breast CancerDepression
- First Posted Date
- 2024-12-27
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 402
- Registration Number
- NCT06748222
Comparing Radiation Therapy to Usual Care for Patients With High-Risk Bone Asymptomatic Metastases
Phase 3
Not yet recruiting
- Conditions
- Metastatic Malignant Neoplasm in the BoneMetastatic Malignant Solid Neoplasm
- First Posted Date
- 2024-12-20
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 280
- Registration Number
- NCT06745024
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Phase 3
Recruiting
- Conditions
- Fallopian Tube Endometrioid AdenocarcinomaFallopian Tube High Grade Serous AdenocarcinomaFIGO Stage III Ovarian Cancer 2014FIGO Stage IV Ovarian Cancer 2014Ovarian CarcinomaOvarian High Grade Endometrioid AdenocarcinomaOvarian High Grade Serous AdenocarcinomaPrimary Peritoneal Endometrioid AdenocarcinomaPrimary Peritoneal High Grade Serous Adenocarcinoma
- Interventions
- Procedure: Biospecimen CollectionProcedure: Computed TomographyProcedure: Magnetic Resonance Imaging
- First Posted Date
- 2024-08-30
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 880
- Registration Number
- NCT06580314
- Locations
- 🇺🇸
University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
🇺🇸Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States
🇺🇸Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Phase 2
Not yet recruiting
- Conditions
- Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Head and Neck Squamous Cell CarcinomaHypopharyngeal Squamous Cell CarcinomaLaryngeal Squamous Cell CarcinomaNasopharyngeal Squamous Cell CarcinomaOral Cavity Squamous Cell CarcinomaOropharyngeal Squamous Cell CarcinomaStage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
- Interventions
- Other: Best PracticeProcedure: Biospecimen CollectionProcedure: Computed TomographyRadiation: Image Guided Radiation TherapyRadiation: Intensity-Modulated Radiation TherapyProcedure: Magnetic Resonance ImagingDrug: Placebo AdministrationDrug: MnSOD Mimetic BMX-001Other: Questionnaire Administration
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 98
- Registration Number
- NCT06532279
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Phase 3
Recruiting
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Digestive System CarcinomaMetastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainMetastatic Malignant Solid NeoplasmMetastatic MelanomaMetastatic Renal Cell CarcinomaStage IV Lung Cancer AJCC v8Stage IV Renal Cell Cancer AJCC v8
- Interventions
- Procedure: Computed TomographyRadiation: Fractionated Stereotactic Radiation TherapyProcedure: Magnetic Resonance ImagingRadiation: Stereotactic Radiosurgery
- First Posted Date
- 2024-07-15
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 269
- Registration Number
- NCT06500455
- Locations
- 🇺🇸
Banner University Medical Center - Tucson, Tucson, Arizona, United States
🇺🇸University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States
🇺🇸Kaiser Permanente-Anaheim, Anaheim, California, United States
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Phase 3
Recruiting
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8Metastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the LeptomeningesStage IV Lung Cancer AJCC v8Metastatic Breast Carcinoma
- Interventions
- Procedure: Biospecimen CollectionProcedure: Computed TomographyRadiation: Involved-Field Radiation TherapyProcedure: Lumbar PunctureProcedure: Magnetic Resonance ImagingProcedure: Positron Emission TomographyRadiation: Proton Beam Craniospinal IrradiationOther: Quality-of-Life Assessment
- First Posted Date
- 2024-07-15
- Last Posted Date
- 2025-03-04
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 115
- Registration Number
- NCT06500481
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸UC San Diego Health System - Encinitas, Encinitas, California, United States
🇺🇸UC San Diego Moores Cancer Center, La Jolla, California, United States
Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer
Phase 2
Recruiting
- Conditions
- Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC v8Stage III Uterine Corpus Endometrial Stromal Sarcoma AJCC v8
- Interventions
- Other: Clinical ObservationProcedure: Computed TomographyProcedure: Magnetic Resonance ImagingProcedure: High-Dose-Rate Vaginal BrachytherapyRadiation: External Beam Radiation TherapyOther: Questionnaire AdministrationProcedure: Positron Emission TomographyProcedure: X-Ray Imaging
- First Posted Date
- 2024-04-29
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 325
- Registration Number
- NCT06388018
- Locations
- 🇺🇸
Grady Health System, Atlanta, Georgia, United States
🇺🇸Alaska Women's Cancer Care, Anchorage, Alaska, United States
🇺🇸University of Arizona Cancer Center-Orange Grove Campus, Tucson, Arizona, United States
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
Not Applicable
Recruiting
- Conditions
- Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
- Interventions
- Other: InterviewOther: CounselingOther: Medical Chart ReviewBehavioral: Health EducationOther: Questionnaire AdministrationOther: Monitoring
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 600
- Registration Number
- NCT06279013
- Locations
- 🇺🇸
Cancer Center at Saint Joseph's, Phoenix, Arizona, United States
🇺🇸Augusta University Medical Center, Augusta, Georgia, United States
🇺🇸John H Stroger Jr Hospital of Cook County, Chicago, Illinois, United States
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3
Recruiting
- Conditions
- Prostate AdenocarcinomaStage III Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8
- Interventions
- Radiation: External Beam Radiation TherapyRadiation: Stereotactic Body Radiation Therapy
- First Posted Date
- 2023-07-14
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 1209
- Registration Number
- NCT05946213
- Locations
- 🇺🇸
Illinois CancerCare-Peru, Peru, Illinois, United States
🇺🇸Farmington Health Center, Farmington, Utah, United States
🇺🇸University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
© Copyright 2025. All Rights Reserved by MedPath